Record #2404
Efficacy and Safety of Induction Dosing of Vedolizumab for Reducing Biliary Inflammation in Primary Sclerosing Cholangitis (Psc) in Individuals with Inflammatory Bowel Disease
Journal
Publisher
Original paper date
Sep 22, 2016
Original DOI
Country
Open access
No
Article type
Notes from Retraction Watch
Given as part of Oral Presentations: Saturday, 16 April 2016: Autoimmune and hepatobiliary diseases;
Citation lifecycle
How this paper is being cited
Pre-retraction
0
Same day
0
Post-retraction
3
% post-retraction
100.0%
~0.0 citations/yr before retraction · ~0.3 citations/yr after
— citing papers
Who is still citing this work
Loading…